Intest Res.  2016 Oct;14(4):293-294. 10.5217/ir.2016.14.4.293.

Could fecal calprotectin enter mainstream use for diagnosing and monitoring inflammatory bowel disease?

• Wei SC

• KMID: 2354945
• DOI: http://doi.org/10.5217/ir.2016.14.4.293

Abstract

No abstract available.

MeSH Terms

Inflammatory Bowel Diseases*
Leukocyte L1 Antigen Complex*
Leukocyte L1 Antigen Complex

Reference

1. Hsu K, Champaiboon C, Guenther BD, et al. Anti-infective protective properties of S100 calgranulins. Antiinflamm Antiallergy Agents Med Chem. 2009; 8:290–305. PMID: 20523765.

2. Tibble J, Teahon K, Thjodleifsson B, et al. A simple method for assessing intestinal inflammation in Crohn's disease. Gut. 2000; 47:506–513. PMID: 10986210.

3. Chang MH, Chou JW, Chen SM, et al. Faecal calprotectin as a novel biomarker for differentiating between inflammatory bowel disease and irritable bowel syndrome. Mol Med Rep. 2014; 10:522–526. PMID: 24788223.

4. D'Haens G, Ferrante M, Vermeire S, et al. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease. Inflamm Bowel Dis. 2012; 18:2218–2224. PMID: 22344983.

5. Lin WC, Wong JM, Tung CC, et al. Fecal calprotectin correlated with endoscopic remission for Asian inflammatory bowel disease patients. World J Gastroenterol. 2015; 21:13566–13573. PMID: 26730169.

6. Wright EK, Kamm MA, De Cruz P, et al. Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn’s disease after surgery. Gastroenterology. 2015; 148:938–947.e1. PMID: 25620670.

7. Kawashima K, Ishihara S, Yuki T, et al. Fecal calprotectin level correlated with both endoscopic severity and disease extent in ulcerative colitis. BMC Gastroenterol. 2016; 16:47. PMID: 27071448.

8. Jang HW, Kim HS, Park SJ, et al. Accuracy of three different fecal calprotectin tests in the diagnosis of inflammatory bowel disease. Intest Res. 2016; 14:305–313.